Upper Extremity Functional Electrical Stimulation (FES) for Restoration of Upper Extremity Function After Spinal Cord Injury (SCI)

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Miami

About this trial

The purpose of this research is to examine the effects that functional electrical stimulation (FES) therapy has on the way the arms, brain and spinal cord work. The study team wants to understand what recovery looks like in persons with a spinal cord injury (SCI) or peripheral nerve injury (PNI) using the MyndMove (MyndTec Inc., Ontario, Canada) therapy system. This type of therapy uses stimulation to help people with SCI and other neurological conditions to perform common tasks, work out, or strengthen muscles.

Eligibility criteria

Qualifiers

Traumatic spinal cord injury (SCI): neurological level at or above T1 spinal cord level; AIS A, B, C or D impairment grade

Group 1 (Acute SCI): Deemed medically stable by medical practitioner, less than 6 months post-injury.

Group 2 (Chronic SCI): More than 6 months post-injury.

Peripheral nerve injury (PNI), with or without SCI, who are pre- or post- upper extremity (UE) nerve transfer surgery

Disqualifiers

Traumatic brain injury, stroke, multiple sclerosis, or other disorders that could affect neuromotor function.

Severe spasticity that could prevent the study protocol as determined by the investigator.

Major executive dysfunction, dementia, depression, neurocognitive impairments, or other major medical co-morbidities.

Has contraindications for transcutaneous stimulation using FES such as breakdown of skin in the area that will come into contact with electrodes, thrombosis, or skin disease

Trial design

Treatments tested in this trial

  • MyndMove Short Term Therapy
  • Conventional Short Term Therapy
  • MyndMove Long Term Therapy

Treatment groups

60 Participants
are divided into 4 treatment groups

Sponsors and collaborators